乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Oncology/Hematology >

Lymphoma

News, opinions and meeting coverage in oncology/hematology.

A computer rendering of CAR-T cells attacking B-cell lymphoma cells.

<乌鸦传媒>If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

Durable response possible with treatment targeting a different antigen

<乌鸦传媒>Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results

R-CHOP plus venetoclax falls short, while R-CHOP with HDAC inhibitor shows promise

A photo of a man standing on a balance board.

<乌鸦传媒>Neuromuscular Training Decreased Incidence of Chemo-Induced Peripheral Neuropathy

Incidence significantly reduced with two types of exercises versus usual care

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials

News, features, and commentary about cancer-related issues

<乌鸦传媒>Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma

Our panel of experts discusses mosunetuzumab/polatuzumab vedotin for relapsed/refractory patients

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer

News, features, and commentary about cancer-related issues

EHA over a photo of IFEMA Madrid in Spain.

<乌鸦传媒>Glofitamab Regimen Improves Survival in DLBCL

Granted accelerated approval last year, bispecific antibody passes its confirmatory test

A computer rendering of diffuse large B-cell lymphoma cells.

<乌鸦传媒>Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

High-rate of durable responses with ViPOR sparks talk of supplanting CAR-T in second line

EHA over a photo of IFEMA Madrid in Spain.

<乌鸦传媒>Atezolizumab Consolidation Impresses in High-Risk DLBCL

Will 2-year DFS of 88%, OS of 96% renew interest in checkpoint inhibitor consolidation?

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

News, features, and commentary about cancer-related issues

A computer rendering of CAR T cell therapy in Diffuse large B-cell lymphoma

<乌鸦传媒>New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy

Co-mutations, viral link, potential common susceptibility emerge from two studies

A photo of Alunbrig (brigatinib) tablets.

<乌鸦传媒>Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

Second-gen ALK inhibitor induces high response rate, associated with impressive survival

A photo of a female radiologist readying her male patient for radiotherapy.

<乌鸦传媒>Near-Perfect Control of Slow-Growing Lymphoma With Low-Dose Radiotherapy

All but four of 24 patients had complete responses to 4 Gy, local control rate of 96% at 3 years

Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

<乌鸦传媒>Star Singer's Illness; AI Imitating the Dead; Internet-Addicted Brains

Health news and commentary gathered by 乌鸦传媒 staff

ASCO over a photo of McCormick Place in Chicago, IL

<乌鸦传媒>Triplet Notches Survival Win in Heavily Pretreated DLBCL

Benefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant

ASCO over a photo of McCormick Place in Chicago, IL

<乌鸦传媒>Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trial

Better efficacy with brentuximab vedotin versus standard chemo, substantially less toxicity

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Fewer Suicides in Cancer Patients; Circadian Rhythm Boost; HIV Vaccine for Cancer?

News, features, and commentary about cancer-related issues

A photo of a male artist tattooing his male client in a parlor in Stockholm, Sweden.

<乌鸦传媒>Tattoos May Be a Risk Factor for Lymphoma

Swedish study suggests a 21% higher risk for lymphoma in those with tattoos

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Cancer and Intimate-Care Products; Boost for CRC Stool Tests; Biopsy by Ultrasound?

News, features, and commentary about cancer-related issues

Illustration of an engineered T-cell attacking a leukemia cell.

<乌鸦传媒>CAR-T Plus Stem-Cell Transplant Promising for CD7+ Blood Cancers

"All-in-one" approach appears safe, effective, in patients with relapsed/refractory disease

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests

News, features, and commentary about cancer-related issues

A photo of a pregnant woman napping while receiving chemotherapy.

<乌鸦传媒>Immunotherapy During Pregnancy Just as Safe as Other Cancer Drugs

However, use should be avoided "if possible" due to risk of rare immune-related adverse events

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Chemo and Heart Disease; Flawed Lung Cancer Screening; New Vax Recommendations

News, features, and commentary about cancer-related issues

A computer rendering of white blood cells with T-cell lymphoma.

<乌鸦传媒>PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma

The combination induced responses in all 34 patients with advanced extranodal NK/T-cell lymphoma

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Broader Cancer Risk With CAR-T? AI for Physician Burnout; 'Lollipops' ID Oral Cancer

News, features, and commentary about cancer-related issues

A photo of a woman reading a book while receiving chemotherapy

<乌鸦传媒>Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors Treated With Doxorubicin

Dose-dependent increase regardless of age at treatment or chest radiotherapy

A photo of a woman holding a tray of stainless equipment at a medical sterilization facility

<乌鸦传媒>EPA Imposes New Limit on Medical Sterilization Chemical, Citing Cancer Risk

Rule would lower emission standards for ethylene oxide by 90%, agency says

FDA APPROVED lisocabtagene maraleucel (Breyanzi) over a computer rendering of CLL cells in the blood stream.

<乌鸦传媒>FDA Approves First CAR-T for Chronic Lymphocytic Leukemia

Lisocabtagene maraleucel (Breyanzi) nabs new indication for relapsed or refractory CLL/SLL

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Getting Prostate Cancer Drugs Sooner; Limiting Toxic Emissions; FTC Sues 'Charity'

News, features, and commentary about cancer-related issues

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu

News, features, and commentary about cancer-related issues

A computer rendering of T-cells attacking a Reed-Sternberg cell in Hodgkin lymphoma.

<乌鸦传媒>Novel Regimens Yield High Response Rates for Older, Hodgkin Lymphoma Patients

Talk of potential cure for some patients with brentuximab plus dacarbazine or nivolumab

A photo of a male technician using a light microscope to inject a sperm into an egg.

<乌鸦传媒>IVF Helps Patients Trying to Build Families. An Alabama Court Put That in Doubt

"Every month that you're not pregnant feels like grief"

A photo of families holding handwritten signs at a protest outside a sterilization plant in Illinois.

<乌鸦传媒>Toxic Gas That Sterilizes Medical Devices Prompts Safety Rule Update

The EPA is set to take action after public outcry

A computer rendering of several sperm swimming towards one side of an egg and very few swimming towards the other side.

<乌鸦传媒>Male Fertility Problems in the Family Linked to Cancer Risk

Low sperm levels were tied to specific cancers in family members

A scanning electron microscope image of a cell heavily infected with SARS-CoV-2 virus particles

<乌鸦传媒>Most Immunocompromised Patients Clear Omicron Infections

B-cell malignancies, B-cell treatments associated with longer duration of infection

A photo of stacked creosote soaked timber next to a railroad track.

<乌鸦传媒>How Can Cancer Risk Be Cut in Communities Exposed to Toxins?

Group outlines plan to bring the latest testing and treatment to medically underserved minorities

A computer rendering of CAR-T immunotherapy.

<乌鸦传媒>CAR-T Investigation: FDA Leaders Detail Decision on Cancer Risk Warning

Post-treatment cases grow to 22 since products' initial approvals

A computer rendering of CAR T cells and a cancer cell.

<乌鸦传媒>FDA Calls for New Boxed Warning on All CAR-T Products

Most serious warning would alert patients, providers on potential risk for secondary malignancies

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancer

News, features, and commentary about cancer-related issues

<乌鸦传媒>Pirtobrutinib Shows Potential in Heavily Pretreated Follicular Lymphoma

"Safety profile is one of the real advantages" of non-covalent BTK inhibitor, says panelist

1